3rd Annual Longevity Therapeutics 2021 Summit
January 26 - 28, 2021 Completed
Nobody has claimed this event yet.
Organizers who claim their event pages can update listing details, add photos, answer to reviews, view click reports and more.Claim your free event listing
Accelerating & Enhancing the Development of Aging Research & Therapeutics Affecting Age-Related Diseases
The Longevity Therapeutics Summit returns for its third year in a fully digital format. Uniting 100+ key senior leaders in the anti-aging research and longevity therapeutics space, this summit is your opportunity to examine the advancement of innovative therapies and drugs.
Specifically focused on targeting, reversing, or delaying the onset of age-related diseases, this annual event will showcase strategies to ultimately enhance health-span and overcome specific R&D challenges in the space.
Join your peers at this digitally hosted event to discuss optimal methods to leverage advanced technologies, from gene therapy to stem cell to senolytics, and embrace novel opportunities to accelerate candidates from preclinical to clinical stages.
Committed to enhancing technical and commercial advancements of therapeutic possibilities for age-related conditions, this summit will once more unite leading biotech drug developers, academics, investors, and pharma companies to progress pioneering anti-aging drugs to the clinic, whilst helping to overcome key preclinical, translational, clinical and regulatory challenges.
Speakers: Adam Freund, Principal Investigator, Calico Labs, Alex Zhavoronkov, Founder & Chief Executive Officer, Insilico, Andrei Gudkov, Chief Scientific Officer, Genome, Aubrey de Grey, Founder & Chief Scientific Officer, SENS Research Foundation, Brian Culley, Chief Executive Officer, Lineage Cell Therapeutics, Colin Watts, Chief Executive Officer, Juvenesce Life, Gordon Lithgow, Professor & Vice President, Academic Affairs, Buck Institute on Aging, Junaid Mian, Managing Partner, SP8CEVC, Kate Batz, Managing Director, Deep Knowledge Ventures, Laura Deming, Partner, The Longevity Fund, Lewis Gruber, Chief Executive & Scientific Officer, Siwa Therapeutics, Lloyd Klickstein, Chief Scientific Officer, resTORbio, Marc Ramis-Castelltort, Co-Founder, Rejuversen, Marco Quarta, CEO & Co-Founder, Rubedo Life Sciences, Mark Allen, Chief Executive Officer, Elevian, Nathaniel David, Co-Founder & President, Unity Biotechnology, Reenie McCarthy, Chief Executive Officer, Stealth BioTherapeutics, Ronald Kohanski, Deputy Director – Division of Aging Biology, National Institute on Aging, NIH, Ronjon Nag, Founder, R42 Institute, Samuel Agus, Chief Medical Officer, Biophytis, Scott Shandler, Chief Executive Officer, Longevity Biotech, Sergio Ruiz, Co-Founder & Managing Director, Methuselah Fund, Steven Braithwaite, Chief Scientific Officer, Alkahest, Steven Engle, Chief Executive Officer, CohBar, Thomas Hughes, Chief Executive Officer, Navitor
Time: On Tuesday January 26, 2021 at 9:00 am (ends Thursday January 28, 2021 at 5:00 pm)
Drug Developer Conference Only USD 1499.00
Drug Developer Conference + 1 Workshop USD 1828.00
Drug Developer Conference + 2 Workshops USD 2157.00
Service Provider Conference Only USD 1999.00
Service Provider Conference + 1 Workshop USD 2358.00
Service Provider Conference + 2 Workshops USD 2717.00
Academic Conference Only USD 1199.00
Academic Conference+ 1 Workshop USD 1448.00
Academic Conference+ 2 Workshops USD 1697.00
Reviews are public and modifiable.